Biohaven Ltd.
NYSE: BHVN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Vladimir Coric
- Employees
- 256
- Headquarters
- New Haven, United States
- IPO year
- 2022
- Market cap
- $1.4B
- Website
- https://www.biohaven.com
Loading BHVN…
Loading profile data…Frequently asked questions about BHVN
What does Biohaven Ltd. (BHVN) do?
Biohaven Ltd. operates as a biopharmaceutical firm actively engaged in clinical trials. Its primary objective is to advance innovative treatments for disorders affecting the nervous and immune systems, with the potential to transform current medical interventions.
Where does BHVN trade?
Biohaven Ltd. (BHVN) trades on the New York Stock Exchange.
What sector is BHVN in?
Biohaven Ltd. (BHVN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Biohaven Ltd.?
Vladimir Coric is the chief executive officer of Biohaven Ltd. (BHVN).
Where is Biohaven Ltd. headquartered?
Biohaven Ltd. is headquartered in United States.
Does BHVN pay a dividend?
Biohaven Ltd. (BHVN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BHVN go public?
Biohaven Ltd. (BHVN) completed its initial public offering in 2022.